Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Market Watch, The Wall Street Journal, 27 May 2014
Accessed on 29 May 2014 from http://www.marketwatch.com/story/genzymes-lemtrada-recommended-for-reimbursement-on-nhs-by-the-national-institute-for-health-and-care-excellence-nice-2014-05-27.